alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### William E. Ackerson et al., Respondents, v Robert L. Mincey et al., Appellants.

Weiss, J.

Appeals (transferred to this court by order of the Appellate Division, Second Depart*935ment) from two orders of the Supreme Court (Benson, J.), entered June 26, 1989 and July 10, 1989 in Dutchess County, which denied defendants’ motion for summary judgment dismissing the complaint.

Plaintiff William E. Ackerson (hereinafter plaintiff) suffered a cervical sprain injury as a result of an accident in which his vehicle was struck from behind on May 23, 1986. Defendants moved for summary judgment based upon the absence of a serious injury as defined in Insurance Law § 5102 (d). Supreme Court found that a triable issue of fact existed as to whether plaintiff’s soft tissue injury was the competent producing cause of a permanent significant limitation of motion of his neck and the aggravation of a preexisting weakened arthritic spine condition. Defendants appeal, contending that plaintiff’s attending physician established that plaintiff did not suffer a serious injury. Defendants further contend that the conclusions set forth in an affidavit from plaintiff’s chiropractor, who first saw plaintiff 1 *Vi*years after the subject accident and more than a year after a subsequent slip and fall in which plaintiff struck his head and suffered another cervical sprain, is palpably incredible.

The attending physician described the nature of plaintiff’s injury and the treatment he rendered. He stated that as of November 14, 1986 (just one week prior to plaintiff’s second injury) there had been no significant improvement in plaintiff’s condition. While the physician indicated difficulty in drawing a direct causal relationship between the May 1986 accident and plaintiff’s December 1987 condition, impossibility was not asserted and the physician clearly indicated that the subject accident contributed to plaintiff’s condition. Moreover, he indicated an objective finding of C8 radiculopathy causing plaintiff’s condition and did not address the degree of pain experienced by plaintiff, nor his range of motion of the neck.

While mild transitory pain without a restriction in mobility is not the basis of a serious injury *(Scheer v Koubek,*70 NY2d 678, 679), in light of defendants’ limited showing *(see, Winegrad v New York Univ. Med. Center,*64 NY2d 851, 853) the objective findings and opinion stated in the chiropractor’s affidavit raise a triable issue of fact *(see, Fenstamacher v Reyell, 152*AD2d 890, 892; *Robbie v Ledeoux,*146 AD2d 764, 765). The chiropractor found a distinct limitation of cervical movement due to pain. Defendants’ criticism of the chiropractor’s affidavit has merely raised issues of credibility *(see, Lopez v Senatore,*65 NY2d 1017, 1020).

*936Orders affirmed, with costs. Casey, J. P., Weiss, Mikoll, Mercure and Harvey, JJ., concur.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Heart, Lung, and Blood Institute Special Emphasis Panel; Clinical Trials SEP (UG3, U24, R61, R34).                    

*Date:*                         July 21, 2021.                              ( print page 30964)    

*Time:*                         10:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6705 Rockledge Drive, Bethesda, MD 20817 (Virtual Meeting).                    

*Contact Person:*                         Zhihong Shan, Ph.D., MD, Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 205-J, Bethesda, MD 20892, (301) 827-7085,                         *zhihong.shan@nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS)

Dated: June 4, 2021.

David W. Freeman,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2021-12138 Filed 6-9-21; 8:45 am]

BILLING CODE 4140-01-P
SCWC-30205
IN THE SUPREME COURT OF THE STATE OF HAWAI # I

STATE OF HAWAI # I, Respondent/Plaintiff-Appellee,

vs. MARYANN ACKER, Petitioner/Defendant-Appellant, and WILLIAM GERALD ACKER, Respondent/Defendant.

CERTIORARI TO THE INTERMEDIATE COURT OF APPEALS

(ICA NO. 30205; CR. NO. 056042)
ORDER DENYING MOTION FOR RECONSIDERATION (By: Recktenwald, C.J., Nakayama, J., and Circuit Judge Nacino, in place of Pollack, J., recused, with Acoba, J., dissenting, with whom McKenna, J., joins) Upon consideration of Petitioner/Defendant-Appellant Maryann Acker’s motion for reconsideration filed on February 24, 2014, and the records and files herein,

IT IS HEREBY ORDERED that the motion is denied. DATED: Honolulu, Hawai # i, February 27, 2014. Keith S. Shigetomi for petitioner /s/ Mark E. Recktenwald /s/ Paula A. Nakayama /s/ Edwin C. Nacino Electronically Filed Supreme Court SCWC-30205 27-FEB-2014 11:55 AM
[Federal Register Volume 61, Number 81 (Thursday, April 25, 1996)]
[Notices]
[Page 18401]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-10184]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Institute of Allergy and Infectious Diseases Special Emphasis 
Panel (SEP) meeting:

    Name of SEP: Master Agreement for HIV Preclinical Vaccine 
Development proposals, tasks E, F and J.
    Date: April 26, 1996.
    Time: 8:00 a.m.
    Place: Washington National Airport Hilton Hotel, 2399 Jefferson 
Davis Highway, Arlington, VA 22202, (703) 418-6800.
    Contact Person: Dr. Allen Stoolmiller, Scientific Review Adm., 
6003 Executive Boulevard, Solar Bldg., Room 4C05, Bethesda, MD 
20892-7610, (301) 496-7966.
    Purpose/Agenda: To evaluate contract proposals.
    The meeting ill be closed in accordance with the provisions set 
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Applications and/or proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.
    This notice is being published less than 15 days prior to the 
meeting due to the urgent need to meet timing limitations imposed by 
the review and funding cycle.

    (Catalog of Federal Domestic Assistance Programs Nos. 93.855, 
Immunology, Allergic and Immunologic Diseases Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health.)

    Dated: April 22, 1996.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 96-10184 Filed 4-24-96; 8:45 am]
BILLING CODE 4140-01-M
EXHIBIT 31.2

CERTIFICATION OF C.F.O. PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Randall J. Frapart, certify
that:

1. I have reviewed this annual report on Form 10-KSB of Datrek Miller International, Inc.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my
knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the
periods presented in this report;

4. The small business issuers other certifying officer(s) and I are responsible for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(d)) for the small business issuer and have:

(a) designed such
disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made
known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) evaluated the effectiveness of the
small business issuers disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such
evaluation; and

(c) disclosed in this report any change in the small business issuers internal control over financial reporting that occurred during
the small business issuers most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the small business issuers internal control over financial reporting; and

5. The small business issuers other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting,
to the small business issuers auditors and the audit committee of the small business issuers board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuers ability
to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees
who have a significant role in the small business issuers internal control over financial reporting.

March 31,
2006



|                           
|---------------------------
|/s/ Randall J. Frapart     
|Randall J. Frapart         
|Principal Financial Officer
[Federal Register Volume 61, Number 90 (Wednesday, May 8, 1996)]
[Notices]
[Page 20867]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-11595]



=======================================================================
-----------------------------------------------------------------------

RAILROAD RETIREMENT BOARD


Sunshine Act Meeting

    Notice is hereby given that the Railroad Retirement Board will hold 
a meeting on May 15, 1996, 9:00 a.m., at the Board's meeting room on 
the 8th floor of its headquarters building, 844 North Rush Street, 
Chicago, Illinois, 60611. The agenda for this meeting follows:

Portion Open to the Public

    (1) Draft Agreements with the Internal Revenue Service.
    (2) OIG'S Reinvention Proposals--Phase II.
    (3) Proposed Reorganizations:
    A. Bureau of Information Systems.
    B. Bureau of Fiscal Operations.
    (4) Office of Programs Restructuring.
    (5) Regulations--Part 230, Final Rule, Reduction and Non-Payment 
of Annuities by Reason of Work.
    (6) Coverage Determinations:
    A. Industrial Temps, Inc.
    B. The Oxford Group, Inc.
    C. OmniTrax, Inc.
    D. Genesee Valley Transportation Company, Inc.
    E. Joliet Junctions Railroad.
    F. SouthCentral Rail Management LLC (SCRM).
    (7) Labor Member Truth in Budgeting Status Report.

Portion Closed to the Public

    (A) Pending Board Apeals:
    (1) Anderson, Raymond.
    (2) Castelluccio, Charles J.
    (3) Crawford, Rick J.
    (4) Fisher, Charles F.
    (5) Fuller, Ralph L.
    (6) Gifford, Donald F.
    (7) Harris, Henry J.
    (8) Herbert, Harold F.
    (9) Howard, Alvira M.
    (10) Hudson, Henry H.
    (11) Knight, Lonice I.
    (12) McLeod, Jasper N.
    (13) Morrison, Georgia L.
    (14) Parker, Jean E.
    (15) Renfrow, Earl F.
    (16) Smith, Clifford R.
    (17) Thorton, Lenill.
    (18) Trybala, Theresa A.
    (19) Vance, Allen L.

    The person to contact for more information is Beatrice Ezerski, 
Secretary to the Board, Phone No. 312-751-4920.

    Dated: May 3, 1996.
Beatrice Ezerski,
Secretary to the Board.
[FR Doc. 96-11595 Filed 5-6-96; 10:52 am]
BILLING CODE 7905-01-M
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5462 Introduced in House (IH)]

<DOC>

118th CONGRESS
  1st Session
                                H. R. 5462

   To amend the Federal Meat Inspection Act and the Poultry Products 
Inspection Act to require that the slaughter date, package date, freeze 
  date, and country of origin be labeled on meat and poultry products.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           September 14, 2023

  Mr. Santos introduced the following bill; which was referred to the 
                        Committee on Agriculture

_______________________________________________________________________

                                 A BILL

 
   To amend the Federal Meat Inspection Act and the Poultry Products 
Inspection Act to require that the slaughter date, package date, freeze 
  date, and country of origin be labeled on meat and poultry products.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. MANDATORY LABELING REQUIREMENTS FOR MEAT AND POULTRY.

    (a) Federal Meat Inspection Act.--Section 1(n) of the Federal Meat 
Inspection Act (21 U.S.C. 601(n)) is amended--
            (1) in paragraph (11), by striking ``or'' at the end;
            (2) in paragraph (12), by striking the period at the end 
        and inserting ``; or''; and
            (3) by adding at the end the following:
            ``(13) if it fails to bear, directly thereon or on its 
        container, as the Secretary may by regulations prescribe--
                    ``(A) the slaughter date;
                    ``(B) the package date;
                    ``(C) if frozen, the freeze date;
                    ``(D) the country of origin; or
                    ``(E) if the country of origin is the United 
                States, the State of origin.''.
    (b) Poultry Product Inspection Act.--Section 4(h) of the Poultry 
Products Inspection Act (21 U.S.C. 453(h)) is amended--
            (1) in paragraph (11), by striking ``or'' at the end;
            (2) in paragraph (12), by striking the period at the end 
        and inserting ``; or''; and
            (3) by adding at the end the following:
            ``(13) if it fails to bear, directly thereon or on its 
        container, as the Secretary may by regulations prescribe--
                    ``(A) the slaughter date;
                    ``(B) the package date;
                    ``(C) if frozen, the freeze date;
                    ``(D) the country of origin; or
                    ``(E) if the country of origin is the United 
                States, the State of origin.''.
                                 <all>
```
<PAGE>

                                                                    EXHIBIT 23.1

                          INDEPENDENT AUDITORS' CONSENT

      We consent to the incorporation by reference in Enterprise Products
Partners L.P. and Enterprise Products Operating L.P.'s (i) Registration
Statement No. 333-36856 of Enterprise Products Partners L.P. on Form S-8; (ii)
Registration Statement No. 333-102778 of Enterprise Products Partners L.P. and
Enterprise Products Operating L.P. on Form S-3; (iii) Registration Statement No.
333-102776 of Enterprise Products Partners L.P. and Enterprise Products
Operating L.P. on Form S-4; and (iv) Registration Statement No. 333-82486 of
Enterprise Products Partners L.P. on Form S-8 of our reports dated February 28,
2003 (such reports express an unqualified opinion and include explanatory
paragraphs referring to the change in accounting for goodwill in 2002 and
derivative instruments in 2001), appearing in the respective Annual Reports on
Form 10-K of Enterprise Products Partners L.P. and Enterprise Products Operating
L.P. for the year ended December 31, 2002.


/s/ DELOITTE & TOUCHE LLP
Houston, Texas
March 28, 2003
[Letterhead of British Columbia Ministry of Finance Corporate and Personal Property Registries]



Notice of Articles

BUSINESS CORPORATIONS ACT

CERTIFIED COPY



Of a Document filed with the Province of

British Columbia Registrar of Companies



/s/ J S Powell

J S Powell

October 14, 2004





This Notice of Articles was issued by the Registrar on:

October 14, 2004 12:14 PM Pacific Time



Incorporation Number:

BC0225083



Recognition Date:

Incorporated on January 22, 1981





NOTICE OF ARTICLES





Name of Company:



VANNESSA VENTURES LTD.





REGISTERED OFFICE INFORMATION



Mailing Address:

Delivery Address:

DUMOULIN BLACK

DUMOULIN BLACK

10TH FLOOR, 595 HOWE STREET

10TH FLOOR, 595 HOWE STREET

VANCOUVER BC V6C 2T5

VANCOUVER BC V6C 2T5







RECORDS OFFICE INFORMATION



Mailing Address:

Delivery Address:

DUMOULIN BLACK

DUMOULIN BLACK

10TH FLOOR, 595 HOWE STREET

10TH FLOOR, 595 HOWE STREET

VANCOUVER BC V6C 2T5

VANCOUVER BC V6C 2T5





---





DIRECTOR INFORMATION



Last Name, First Name Middle Name:

CHAPEL, GEORGE D.



Mailing Address:

Delivery Address:

SUITE 220, 1010 - 1ST STREET S.W.

SUITE 220, 1010 - 1ST STREET S.W.

CALGARY AB T2R 1K4

CALGARY AB T2R 1K4





Last Name, First Name Middle Name:

THOMAS, JOHN



Mailing Address:

Delivery Address:

SUITE 220, 1010 - 1ST STREET S.W.

SUITE 220, 1010 - 1ST STREET S.W.

DELTA BC

DELTA BC

CALGARY AB T2R 1K4

CALGARY AB T2R 1K4





Last Name, First Name Middle Name:

RAUGUTH, ERICH



Mailing Address:

Delivery Address:

SUITE 220, 1010 - 1ST STREET S.W.

SUITE 220, 1010 - 1ST STREET S.W.

CALGARY AB T2R 1K4

CALGARY AB T2R 1K4





Last Name, First Name Middle Name:

PESCHKE, MANFRED



Mailing Address:

Delivery Address:

SUITE 220, 1010 - 1ST STREET S.W.

SUITE 220, 1010 - 1ST STREET S.W.

CALGARY AB T2R 1K4

CALGARY AB T2R 1K4





Last Name, First Name Middle Name:

MORGAN, JOHN A.



Mailing Address:

Delivery Address:

SUITE 220, 1010 - 1ST STREET S.W.

SUITE 220, 1010 - 1ST STREET S.W.

CALGARY AB T2R 1K4

CALGARY AB T2R 1K4









---





Last Name, First Name Middle Name:

HALL, VERN



Mailing Address:

Delivery Address:

SUITE 220, 1010 - 1ST STREET S.W.

SUITE 220, 1010 - 1ST STREET S.W.

CALGARY AB T2R 1K4

CALGARY AB T2R 1K4





Last Name, First Name Middle Name:

AMUNDRUD, JOHN



Mailing Address:

Delivery Address:

SUITE 220, 1010 - 1ST STREET S.W.

SUITE 220, 1010 - 1ST STREET S.W.

CALGARY AB T2R 1K4

CALGARY AB T2R 1K4











AUTHORIZED SHARE STRUCTURE





1.  250,000,000

Common Shares

Without Par Value



Without Special Rights or

Restrictions attached
| 1. | The Annual Report on Form 10K/A (Amendment No. 1) of the Company for the Year ended December 31, 2009 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and |
|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------|

| Dated: April 15, 2010 | /S/       PAUL MILLER           PAUL MILLER           Chief Executive Officer      |
|-----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Dated: April 15, 2010 | /S/       JACQUELINE FLYNN           JACQUELINE FLYNN           Chief Financial Officer |
I 

118TH CONGRESS 

1ST SESSION H. R. 5593 

To amend the Trade Act of 1974 to exempt from the Generalized System 

of Preferences certain tire articles, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

SEPTEMBER 20, 2023 

Mr. HIGGINS of New York (for himself and Mr. WESTERMAN) introduced the 

following bill; which was referred to the Committee on Ways and Means 

A BILL 

To amend the Trade Act of 1974 to exempt from the Generalized System of Preferences certain tire articles, and 

for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. EXCLUSION OF IMPORT-SENSITIVE TIRE ARTI4 CLES. 

5 Section 503(b)(1) of the Trade Act of 1974 (19 

6 U.S.C. 2463(b)(1)) is amended— 

7 (1) by redesignating subparagraph (G) as sub8 paragraph (H); and 

9 (2) by inserting after subparagraph (F) the fol10 lowing new subparagraph: 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 5593 IH

1 ‘‘(G) Import-sensitive tire articles.’’. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
EXHIBIT 32



<PAGE>

     In connection with the quarterly report of New Taohuayuan Culture Tourism
Co., Ltd., (the "Company") on Form 10-Q for the quarter ended June 30, 2009 as
filed with the Securities and Exchange Commission on the date hereof (the
"Report") Cai Danmei, the Principal Executive and Financial Officer of the
Company, certifies pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of her
knowledge:

     (1)  The Report fully complies with the requirements of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and results of operation of
          the company.


August 14, 2009                        By:  /s/ Cai Danmei
                                           -----------------------------------
                                           Cai Danmei, Principal Executive and
                                           Principal Financial Officer